Posted on 3/4/20
Cytrellis Recognized as Finalist for Prestigious Innovation of the Year Award
Cytrellis, a medical technology company developing a new, proprietary class of micro-coring aesthetic devices for the reduction of sagging skin associated with aging,* was named first . . .
Posted on 3/3/20
Trump to Meet With Pharmaceutical Companies About Coronavirus
President Donald Trump will hold talks with executives from major pharmaceutical companies at 4 p.m. EDT Monday regarding the rapidly spreading SARS-CoV-2 coronavirus and the disease . . .
Posted on 3/3/20
Novartis Subsidiary Agrees to Pay $195 Million Over Price-Fixing Charges
Novartis (NYSE:NVS) subsidiary Sandoz has plead guilty in its ongoing price-fixing case. The U.S. Justice Department, which has been investigating price-fixing schemes within the generic-drug industry, . . .
Posted on 3/2/20
Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
NEWTON, Mass., March 02, 2020 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced the commencement of a registered underwritten public offering . . .
Posted on 3/2/20
uniQure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, March 02, 2020 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients . . .
Posted on 3/2/20
Fresenius Kidney Care Launches Online Kidney Care Community
Fresenius Kidney Care, a division of Fresenius Medical Care North America (FMCNA) and the nation's leading network of dialysis facilities, has launched an online community to . . .
Posted on 3/2/20
Boston Biomedical Announces Investment by its Parent Company in MPM Oncology Innovations Fund
Boston Biomedical, Inc. announced today that its parent company, Sumitomo Dainippon Pharma Co., Ltd. (Osaka, Japan) has invested in the MPM Oncology Innovations Fund, and made . . .
Posted on 3/2/20
Trinity Life Sciences Continues to See Inflective Growth in Health Economics and Outcomes Research Practice
WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a global leader in life sciences solutions, today announced it continues to see inflective growth in its Health Economics and Outcomes . . .
Posted on 3/2/20
Seres Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Highlights
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc., (Nasdaq: MCRB) today reported fourth quarter and full year 2019 financial results and provided an operational update.“Throughout 2019, we reinforced Seres’ . . .
Posted on 3/2/20
Diversified Healthcare Trust Announces Fourth Quarter and Year End 2019 Results
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) (formerly known as Senior Housing Properties Trust) today announced its financial results for the quarter and year ended December . . .
Posted on 3/2/20
Xilio Therapeutics Closes $100.5 Million Series B
Xilio Therapeutics, a company developing potent, tumor-selective immuno-oncology (IO) therapies for patients with cancer, today announced the closing of a $100.5 million Series B financing.
Posted on 3/2/20
Bristol-Myers Squibb: Market Uncertainty Makes For A (Potential) Buying Opportunity
SummaryHealthcare stock prices are being driven down by a triple whammy of coronavirus fears, Bernie Sanders front-running the Democrat nomination race, and a falling overall market.As . . .
Posted on 3/2/20
Biogen Could Score a Major Win if Alzheimer's Drug Gets the Green Light
Biogen (NASDAQ:BIIB) had investors more than a little concerned in 2019. The company's efforts to win approval for its highly anticipated Alzheimer's medication, aducanumab, were met . . .
Posted on 3/2/20
Former Biogen CEO to Become Biotech's New Coronavirus Czar
The Biotechnology Innovation Organization (BIO) has officially tapped former Biogen (NASDAQ:BIIB) CEO George Scangos to coordinate the trade association's coronavirus containment effort. Scangos served as CEO . . .
Posted on 3/2/20
Verastem Oncology Announces $100M Private Placement Offering of Common Stock
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ: VSTM), today announced that it has agreed to sell approximately 46.5 million shares of its common stock to certain institutional investors, including . . .
Posted on 2/28/20
Sage Therapeutics Disappoints With Its Q4 Report
Shares of Sage Therapeutics (NASDAQ:SAGE) tumbled Thursday morning after the company reported slower-than-expected revenue growth for its drug for post-partum depression (PPD), and didn't have anything . . .
Posted on 2/28/20
Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%
Sangamo Therapeutics (NASDAQ:SGMO) announced after the bell on Thursday that it signed a partnership with Biogen (NASDAQ:BIIB) to develop a number of gene-editing treatments. The scope . . .
Posted on 2/27/20
Jounce Therapeutics Reports Q4 and Full Year 2019 Financial Results
CAMBRIDGE, Mass., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies . . .
Posted on 2/27/20
Curis Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into . . .
Posted on 2/27/20
Bristol-Myers' Liso-Cel Given Priority Review, Ability To Change Scope Of Treatment
SummaryThe FDA accepted the BLA for liso-cel to treat patients with relapsed/refractory diffuse large B-cell lymphoma.A PDUFA date for liso-cel for the treatment of patients with . . .
Posted on 2/26/20
Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
CAMBRIDGE, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat . . .
Posted on 2/26/20
Why CVS Health Is Falling Again
What happenedFor the second day in a row, shares of CVS Health (NYSE:CVS) are under pressure, falling as much as 5% on Tuesday. Once again, there . . .
Posted on 2/26/20
Oncologie Announces Collaboration with Moffitt Cancer Center
Oncologie, Inc., a clinical-stage biopharmaceutical company developing innovative oncology treatments targeting the tumor microenvironment (TME), announced today that it has entered into a collaboration agreement with . . .
Posted on 2/26/20
Bicycle Therapeutics Announces Exclusive Strategic Collaboration with Genentech
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide . . .
Posted on 2/25/20
Lantheus Holdings Reports Fourth Quarter and Full Year 2019 Financial Results
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc, a global leader in the development, manufacture and commercialization of innovative . . .

